Markets

NuScale Shares Rise on Nuclear Sector Optimism Amid Regulatory Advances

NuScale Power shares rose 3.6% to $13.13 on Monday, outperforming small-cap peers as the nuclear sector gained momentum from U.S. regulatory reforms for small modular reactors.

Daniel Marsh · · 3 min read · 1 views
NuScale Shares Rise on Nuclear Sector Optimism Amid Regulatory Advances
Mentioned in this article
SMR $12.89 +1.74%

NuScale Power shares climbed in late New York trading on Monday, outpacing the broader small-cap market as investors continued to bet on the nuclear energy sector despite the absence of any company-specific news. The stock rose 3.6% to $13.13, reaching as high as $13.40 during the session, on heavy volume of approximately 37.5 million shares. In comparison, the SPDR S&P 500 ETF edged up 0.3%, while the iShares Russell 2000 ETF slipped 0.3%.

Sector Momentum Drives the Move

The rally appears to be driven by sector-wide momentum rather than a new announcement from NuScale. The company's press release page still lists its May 7 first-quarter earnings as the most recent update, and its investor calendar shows management appearances scheduled for Tuesday at the UBS Cleanpower Expo and the RBC Capital Markets Global Energy, Power & Infrastructure Conference. The nuclear sector remained in focus after Reuters Events reported last week that the U.S. Nuclear Regulatory Commission (NRC) is advancing reforms to speed up licensing for small and microreactors. This push is tied to rising electricity demand from data centers and manufacturing, which has renewed interest in advanced nuclear technologies.

Financial Highlights and Dilution Concerns

NuScale's first-quarter results revealed a challenging financial picture. Revenue fell to $565,000 from $13.4 million a year earlier, reflecting the completion of licensing work for the RoPower project in Romania and Fluor engineering activities in 2025. The company reported a net loss attributable to Class A stockholders of $44.0 million. Despite the weak revenue, NuScale ended the quarter with $1 billion in liquidity and capital resources. However, the company has been actively raising cash through its at-the-market (ATM) stock program, which allows it to sell shares up to $1 billion. During the first quarter, it sold 3.16 million shares for $37.9 million in gross proceeds, and after March 31, it sold an additional 22.36 million shares for $216.8 million. While this provides a useful cash source, it also poses a dilution risk for existing shareholders.

Mixed Performance Among Nuclear Peers

The performance of other nuclear-related stocks was mixed on Monday. Oklo rose 1.1% and Nano Nuclear Energy gained 4.0%, while larger nuclear generator Constellation Energy fell 6.6%. This divergence suggests that traders are distinguishing between speculative reactor developers and established power producers.

Analyst Sentiment and Legal Risks

Wall Street remains cautious on NuScale. According to StockAnalysis, citing S&P Global Market Intelligence, 17 analysts have a consensus 'Hold' rating with an average price target of $15.36. Bank of America Securities analyst Dimple Gosai initiated coverage with a 'Hold' rating and a $12 target on May 22. The company also faces a securities lawsuit related to statements about ENTRA1 Energy's experience and capabilities, for which NuScale said it cannot estimate any potential loss.

Outlook and Key Challenges

NuScale's competitive edge lies in its regulatory and technical achievements. The company's NuScale Power Module is a pressurized-water reactor capable of generating 77 megawatts of electricity, scalable up to 924 megawatts, and it holds the first and only small modular reactor (SMR) design certified by the NRC. However, the path to profitability remains uncertain. The company must convert its planning work into binding, financed orders while managing dilution risks, construction costs, supply chain readiness, and utility approval timelines. Monday's price action indicates that investors are still willing to pay for the optionality in nuclear power, but the next test will be whether NuScale can translate this interest into signed projects and revenue before dilution, delays, or legal issues take precedence.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →